Vaping’s Risks to CV Health Not Yet Fully Known: AHA
A new scientific statement outlines potential acute and chronic effects, regulatory and public health efforts, and knowledge gaps.
Related Articles
AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE
The algorithm can identify noncoronary signals, offering insights into ventricular function and cardiac index, investigators say.
More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis
Going forward, data from these kinds of studies could increasingly be used by AI to help personalize therapy for HF patients, an editorial suggests.
More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis
Going forward, data from these kinds of studies could increasingly be used by AI to help personalize therapy for HF patients, an editorial suggests.
Balancing Hypertension and Fall Risk: A Delicate Dance in Elderly Patients
The study of VA patients suggests that starting a new BP drug increases the risk of falls and fractures, likely due to hypotension.
BE ACTIVE: Gaming for Points and Money Can Boost Step Counts
Even after the intervention ended, most people kept making progress, but now it’s time to look for an impact on outcomes.
New Heart Failure After AF Diagnosis Merits More Attention
Prevention of stroke gets highlighted by guidelines and is top-of-mind for patients, but heart failure is much more common.
Diltiazem and DOAC Interaction Increases Bleeding Risk in AF
Physicians have adopted a one-size-fits-all approach to direct oral anticoagulants that must be reconsidered, says Geoffrey Barnes.
FDA Approves First Transcatheter Tricuspid Valve Replacement Device
Edwards Lifesciences says there are “favorable trends” in hard outcomes among patients who have completed 1-year follow-up.
BE ACTIVE: Gaming for Points and Money Can Boost Step Counts
Even after the intervention ended, most people kept making progress, but now it’s time to look for an impact on outcomes.
UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI
D2B times are worrisome: just a third of STEMI patients were treated within the guideline-recommended 150 minutes.